» Articles » PMID: 19248449

Poor Physical Health and Mortality in Patients with Schizophrenia

Overview
Journal Nurs Stand
Specialty Nursing
Date 2009 Mar 3
PMID 19248449
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia, its treatment and the lifestyle of patients contribute to high rates of mortality. Patients often have poorer diets, lower rates of physical activity and smoke more than the general population. Such lifestyle choices predispose them to physical health problems and disease. This article explores the impact of poor physical health on mortality in patients with schizophrenia. Suggestions are made for patient education and promotion of a healthy lifestyle to improve the quality of life for patients with the illness.

Citing Articles

Effect of strength-based physical exercise on telomere length as a marker of premature ageing in patients with schizophrenia: study protocol for a pilot randomised controlled trial.

Sanchez-Gonzalez J, Juarez-Vela R, Dutil Munoz de la Torre V, Andres-Olivera M, Martin-Vallejo J, Moran-Bayon A BJPsych Open. 2024; 10(5):e162.

PMID: 39324245 PMC: 11457242. DOI: 10.1192/bjo.2024.753.


Metabolic Syndrome and Dietary Habits in Hospitalized Patients with Schizophrenia: A Cross-Sectional Study.

Soric T, Mavar M, Rumbak I Medicina (Kaunas). 2021; 57(3).

PMID: 33801842 PMC: 8001284. DOI: 10.3390/medicina57030255.


Inequitable Physical Illness and Premature Mortality for People with Severe Mental Illness in Australia: A Social Analysis.

Edmunds M Health Hum Rights. 2018; 20(1):273-281.

PMID: 30008569 PMC: 6039742.


Lifestyles of Patients with Functional Psychosis Compared to Those of a Sample of the Regional General Population: Findings from a Study in a Community Mental Health Service of the Veneto Region, Italy.

Berti L, Bonfioli E, Chioffi L, Morgante S, Mazzi M, Burti L Community Ment Health J. 2018; 54(7):1050-1056.

PMID: 29349727 DOI: 10.1007/s10597-017-0223-7.


Risperidone-induced metabolic dysfunction is attenuated by Curcuma longa extract administration in mice.

Auger F, Martin F, Petrault O, Samaillie J, Hennebelle T, Trabelsi M Metab Brain Dis. 2017; 33(1):63-77.

PMID: 29034440 DOI: 10.1007/s11011-017-0133-y.